title: A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan.
authors.affiliation: Pfizer, New Taipei City, Taiwan.
authors.forename: C H
authors.initials: CH
authors.lastname: Fang
authors.affiliation: Kantar Health, Taipei, Taiwan.
authors.forename: K Y
authors.initials: KY
authors.lastname: Lin
authors.affiliation: Pfizer Limited, New Taipei City, Taiwan.
authors.forename: Y C
authors.initials: YC
authors.lastname: Huang
authors.affiliation: Pfizer, New York, NY, USA.
authors.forename: L
authors.initials: L
authors.lastname: Liu